PortfoliosLab logoPortfoliosLab logo
PHG vs. PFE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PHG vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Koninklijke Philips N.V. (PHG) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PHG achieves a -2.74% return, which is significantly lower than PFE's 5.18% return. Over the past 10 years, PHG has underperformed PFE with an annualized return of 1.34%, while PFE has yielded a comparatively higher 1.85% annualized return.


PHG

1D
-0.31%
1M
0.37%
YTD
-2.74%
6M
-6.07%
1Y
15.52%
3Y*
11.93%
5Y*
-12.78%
10Y*
1.34%

PFE

1D
-0.82%
1M
-2.06%
YTD
5.18%
6M
2.42%
1Y
16.11%
3Y*
-7.32%
5Y*
-3.51%
10Y*
1.85%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PHG vs. PFE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PHG
Koninklijke Philips N.V.
-2.74%10.87%8.53%55.64%-57.64%-30.75%11.00%42.23%-4.92%26.32%
PFE
Pfizer Inc.
5.18%0.65%-2.22%-41.26%-10.41%66.70%3.07%-6.91%24.82%15.90%

Correlation

The correlation between PHG and PFE is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.37

Correlation (3Y)
Calculated over the trailing 3-year period

0.28

Correlation (5Y)
Calculated over the trailing 5-year period

0.25

Correlation (10Y)
Calculated over the trailing 10-year period

0.28

Correlation (All Time)
Calculated using the full available price history since Aug 14, 2012

0.30

The correlation between PHG and PFE shifts across timeframes, from 0.25 (5 years) to 0.37 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

PHG:

$24.55B

PFE:

$145.22B

EPS

PHG:

$1.01

PFE:

$1.31

PE Ratio

PHG:

25.12

PFE:

19.31

PEG Ratio

PHG:

13.04

PFE:

0.35

PS Ratio

PHG:

1.38

PFE:

2.28

PB Ratio

PHG:

2.15

PFE:

1.61

Total Revenue (TTM)

PHG:

$17.71B

PFE:

$63.32B

Gross Profit (TTM)

PHG:

$8.00B

PFE:

$43.91B

EBITDA (TTM)

PHG:

$2.65B

PFE:

$16.94B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PHG vs. PFE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PHG
PHG Risk / Return Rank: 5555
Overall Rank
PHG Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
PHG Sortino Ratio Rank: 5353
Sortino Ratio Rank
PHG Omega Ratio Rank: 5252
Omega Ratio Rank
PHG Calmar Ratio Rank: 5656
Calmar Ratio Rank
PHG Martin Ratio Rank: 5858
Martin Ratio Rank

PFE
PFE Risk / Return Rank: 6161
Overall Rank
PFE Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
PFE Sortino Ratio Rank: 5757
Sortino Ratio Rank
PFE Omega Ratio Rank: 5555
Omega Ratio Rank
PFE Calmar Ratio Rank: 6767
Calmar Ratio Rank
PFE Martin Ratio Rank: 6565
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PHG vs. PFE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Koninklijke Philips N.V. (PHG) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PHGPFEDifference

Sharpe ratio

Return per unit of total volatility

0.52

0.68

-0.15

Sortino ratio

Return per unit of downside risk

0.99

1.18

-0.19

Omega ratio

Gain probability vs. loss probability

1.12

1.14

-0.02

Calmar ratio

Return relative to maximum drawdown

0.70

1.41

-0.71

Martin ratio

Return relative to average drawdown

1.71

2.91

-1.21

PHG vs. PFE - Sharpe Ratio Comparison

The current PHG Sharpe Ratio is 0.52, which is comparable to the PFE Sharpe Ratio of 0.68. The chart below compares the historical Sharpe Ratios of PHG and PFE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PHGPFEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.52

0.68

-0.15

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.34

-0.14

-0.20

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.04

0.08

-0.04

Sharpe Ratio (All Time)

Calculated using the full available price history

0.20

0.23

-0.03

Drawdowns

PHG vs. PFE - Drawdown Comparison

The maximum PHG drawdown since its inception was -79.61%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for PHG and PFE.


Loading charts...

Drawdown Indicators


PHGPFEDifference

Max Drawdown

Largest peak-to-trough decline

-79.61%

-58.96%

-20.65%

Max Drawdown (1Y)

Largest decline over 1 year

-22.27%

-11.47%

-10.80%

Max Drawdown (3Y)

Largest decline over 3 years

-33.81%

-40.75%

+6.94%

Max Drawdown (5Y)

Largest decline over 5 years

-78.55%

-58.96%

-19.59%

Max Drawdown (10Y)

Largest decline over 10 years

-79.61%

-58.96%

-20.65%

Current Drawdown

Current decline from peak

-52.63%

-47.49%

-5.14%

Average Drawdown

Average peak-to-trough decline

-29.22%

-17.68%

-11.54%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.11%

5.54%

+3.57%

Volatility

PHG vs. PFE - Volatility Comparison

Koninklijke Philips N.V. (PHG) has a higher volatility of 7.00% compared to Pfizer Inc. (PFE) at 4.07%. This indicates that PHG's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PHGPFEDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.00%

4.07%

+2.93%

Volatility (6M)

Calculated over the trailing 6-month period

22.19%

14.64%

+7.55%

Volatility (1Y)

Calculated over the trailing 1-year period

29.78%

23.85%

+5.93%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

37.49%

25.49%

+12.00%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.02%

23.88%

+8.14%

Dividends

PHG vs. PFE - Dividend Comparison

PHG's dividend yield for the trailing twelve months is around 4.00%, less than PFE's 6.79% yield.


PositionTTM20252024202320222021202020192018201720162015
PFE
Pfizer Inc.
6.79%6.91%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.53%3.69%3.47%
PHG
Koninklijke Philips N.V.
4.00%3.27%0.00%0.00%6.43%2.80%0.00%1.97%2.82%2.02%2.51%2.98%

Financials

PHG vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between Koninklijke Philips N.V. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00B10.00B15.00B20.00B25.00B20222023202420252026
3.97B
14.45B
(PHG) Total Revenue
(PFE) Total Revenue
Values in USD except per share items

PHG vs. PFE - Profitability Comparison

The chart below illustrates the profitability comparison between Koninklijke Philips N.V. and Pfizer Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%20222023202420252026
45.2%
67.3%
Portfolio components
PHG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Koninklijke Philips N.V. reported a gross profit of 1.79B and revenue of 3.97B. Therefore, the gross margin over that period was 45.2%.

PFE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a gross profit of 9.72B and revenue of 14.45B. Therefore, the gross margin over that period was 67.3%.

PHG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Koninklijke Philips N.V. reported an operating income of 212.44M and revenue of 3.97B, resulting in an operating margin of 5.4%.

PFE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported an operating income of 4.03B and revenue of 14.45B, resulting in an operating margin of 27.9%.

PHG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Koninklijke Philips N.V. reported a net income of 153.48M and revenue of 3.97B, resulting in a net margin of 3.9%.

PFE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pfizer Inc. reported a net income of 2.69B and revenue of 14.45B, resulting in a net margin of 18.6%.


Frequently Asked Questions


PHG and PFE have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PHG has higher volatility (7.00%) compared to PFE (4.07%). In terms of maximum drawdown, PHG dropped -79.61% vs PFE's -58.96%.

PFE currently has the higher Sharpe Ratio (0.68 vs 0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PHG and PFE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer